{
  "patientInformation": {
    "name": "Sarah Miller",
    "mrn": "MC-001001",
    "dateOfBirth": "1962-03-15",
    "age": 63,
    "sex": "Female"
  },
  "presentingComplaint": "Severe fatigue, jaundice, epigastric pain, confusion",
  "medicalHistory": {
    "conditions": [
      "Rheumatoid arthritis",
      "Essential hypertension",
      "Mild chronic kidney disease"
    ],
    "allergies": [
      "Penicillin (rash)"
    ],
    "socialHistory": "Drinks ~1\n–2 beers/day (7\n–14 units/week); denies bingeing. Smoked ~1 pack/day (35 pack-year history); quit in 2017."
  },
  "medications": {
    "chronicPriorToEvent": [
      "Methotrexate 20 mg weekly",
      "Folic Acid 5 mg weekly",
      "Lisinopril 10 mg daily"
    ],
    "initiatedAtAcuteEvent": "Trimethoprim-Sulfamethoxazole 800/160 mg BID"
  },
  "keyLaboratoryFindings": {
    "encounterDate": "2025-06-21",
    "results": [
      {
        "test": "ALT",
        "value": "1650 U/L",
        "flag": "H",
        "reference": "7.0 - 56",
        "note": "↑↑↑"
      },
      {
        "test": "AST",
        "value": "2100 U/L",
        "flag": "H",
        "reference": "8.0 - 40",
        "note": "↑↑↑↑"
      },
      {
        "test": "ALP",
        "value": "350 U/L",
        "flag": "H",
        "reference": "40 - 150",
        "note": "↑↑"
      },
      {
        "test": "Total Bilirubin",
        "value": "12.5 mg/dL",
        "flag": "H",
        "reference": "0.2 - 1.2",
        "note": "↑↑↑↑"
      },
      {
        "test": "INR",
        "value": "1",
        "flag": "",
        "reference": "0.8 - 1.2",
        "note": "Normal"
      }
    ]
  },
  "diagnosis": {
    "main": "Drug-Induced Liver Injury (DILI) and Methotrexate Toxicity",
    "causality": "Acute liver injury likely due to TMP-SMX and Methotrexate toxicity. Patient developed jaundice, confusion, and hepatic tenderness shortly after initiating TMP-SMX while on chronic Methotrexate therapy.",
    "mechanism": "TMP-SMX can raise free methotrexate levels and impair folate metabolism, potentiating hepatocellular necrosis. Synergistic hepatotoxicity between TMP-SMX and Methotrexate is suspected."
  },
  "differentialDiagnosisTracker": {
    "diagnoses": [
      {
        "name": "Drug-Induced Liver Injury (DILI)",
        "status": "PRIMARY",
        "notes": "Highly probable given timing of TMP-SMX initiation and clinical presentation."
      },
      {
        "name": "Methotrexate Toxicity",
        "status": "PRIMARY",
        "notes": "Concomitant drug, known hepatotoxic, interacts with TMP-SMX."
      },
      {
        "name": "Acute viral hepatitis",
        "status": "INVESTIGATE",
        "notes": "Pending serology."
      },
      {
        "name": "Severe methotrexate toxicity",
        "status": "INVESTIGATE",
        "notes": "Pancytopenia and renal injury present; hepatic injury prominent."
      },
      {
        "name": "Acute decompensation of undiagnosed chronic liver disease",
        "status": "PENDING",
        "notes": "No prior history, but considered."
      },
      {
        "name": "Sepsis with multiorgan dysfunction",
        "status": "PENDING",
        "notes": "No fever or hemodynamic instability reported, but considered in context of ALF."
      }
    ],
    "ruledOut": []
  }
}